key: cord-0055535-qxq13kgr
authors: Zhang, Jia-Jia; Hong, Jiang; Ma, Yu-Shui; Shi, Yi; Zhang, Dan-Dan; Yang, Xiao-Li; Jia, Cheng-You; Yin, Yu-Zhen; Jiang, Geng-Xi; Fu, Da; Yu, Fei
title: Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression
date: 2021-01-06
journal: Dis Markers
DOI: 10.1155/2021/6696198
sha: de4edbdcc334fadd2368be498bbcbb2e29a30a59
doc_id: 55535
cord_uid: qxq13kgr

Non-small-cell lung cancer (NSCLC) is one of the most devastating diseases worldwide. The study is aimed at identifying reliable prognostic biomarkers and to improve understanding of cancer initiation and progression mechanisms. RNA-Seq data were downloaded from The Cancer Genome Atlas (TCGA) database. Subsequently, comprehensive bioinformatics analysis incorporating gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and the protein-protein interaction (PPI) network was conducted to identify differentially expressed genes (DEGs) closely associated with NSCLC. Eight hub genes were screened out using Molecular Complex Detection (MCODE) and cytoHubba. The prognostic and diagnostic values of the hub genes were further confirmed by survival analysis and receiver operating characteristic (ROC) curve analysis. Hub genes were validated by other datasets, such as the Oncomine, Human Protein Atlas, and cBioPortal databases. Ultimately, logistic regression analysis was conducted to evaluate the diagnostic potential of the two identified biomarkers. Screening removed 1,411 DEGs, including 1,362 upregulated and 49 downregulated genes. Pathway enrichment analysis of the DEGs examined the Ras signaling pathway, alcoholism, and other factors. Ultimately, eight prioritized genes (GNGT1, GNG4, NMU, GCG, TAC1, GAST, GCGR1, and NPSR1) were identified as hub genes. High hub gene expression was significantly associated with worse overall survival in patients with NSCLC. The ROC curves showed that these hub genes had diagnostic value. The mRNA expressions of GNGT1 and NMU were low in the Oncomine database. Their protein expressions and genetic alterations were also revealed. Finally, logistic regression analysis indicated that combining the two biomarkers substantially improved the ability to discriminate NSCLC. GNGT1 and NMU identified in the current study may empower further discovery of the molecular mechanisms underlying NSCLC's initiation and progression.

As one of the most devastating diseases worldwide, lung cancer causes nearly 1.6 million mortalities each year [1] [2] [3] . Approximately 85% of lung cancers are characterized as non-small-cell lung cancer (NSCLC) [4] [5] [6] , which is typically classified into two subtypes, squamous cell carcinoma (SCC) and adenocarcinoma (AD), using standard pathology methods [7] [8] [9] [10] . Tobacco smoking is the most common risk factor for lung cancer. Smoking is also associated with multiple risks, including worse tolerance of treatment, higher risk of failure and second primary tumors, and poorer quality of life. Indeed, it has become clear that the significant reduction in tobacco consumption would result in the prevention of a large fraction of lung cancer cases and other smokingrelated diseases [11] [12] [13] .

In addition, other factors such as air pollution, poor diet, occupational exposure, and hereditary factors have been reported in association with NSCLC in nonsmokers [14] [15] [16] .

Over the past few years, newly developed cytotoxic agents, including paclitaxel, gemcitabine, and vinorelbine, have emerged to offer multiple therapeutic choices for patients with LUAD [17] [18] [19] [20] . However, chemotherapy for advanced NSCLC is often considered ineffective or excessively toxic [21] [22] [23] .

In an attempt to improve treatments for NSCLC, new therapeutic strategies, such as the development of noncytotoxic targeted agents, have emerged [24] [25] [26] [27] . Moreover, the targeted therapies have significantly improved clinical outcomes in a subset of lung cancer patients whose tumors harbor EGFR [28] , ALK [29, 30] , and HER2 alterations [31] [32] [33] .

Despite recent advances in cancer treatment, unfortunately, the current five-year survival rate of NSCLC remains unsatisfactory [34] [35] [36] [37] . Thus, it is imperative to identify potential biomarkers and explore NSCLC's underlying biological mechanisms.

In recent years, bioinformatics analysis has been utilized as a powerful tool to explore novel prognostic and therapeutic biomarkers and to unveil the potential mechanisms of NSCLC [38] [39] [40] [41] . For instance, a novel model including seven genes was reported to indicate a promising prognostic biomarker for lung SCC patients using integrated bioinformatics methods [41] [42] [43] . In addition, studies used comprehensive bioinformatics analysis to show that the cell cycle pathway may play a significant role in NSCLC in nonsmokers [44] [45] [46] [47] .

In the present study, RNA-Seq data were downloaded from The Cancer Genome Atlas (TCGA) database. Then, the EdgeR package was applied to uncover differentially expressed genes (DEGs) between NSCLC tissues and normal tissues. Using the resulting data, this study is aimed at unveiling the underlying molecular mechanism of NSCLC onset and progression through gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, and the protein-protein interaction (PPI) network. Subsequently, cytoHubba, a novel Cytoscape plugin, was used to reveal the hub genes from 12 topological analysis methods. Furthermore, the prognostic and diagnostic values of the hub genes were further confirmed by survival analysis and receiver operating characteristic (ROC) curve analysis.

The screening revealed two key genes, GNGT1 and NMU, and the protein expressions of these genes were validated by the Human Protein Atlas online database at the system level. Their genetic alteration and coexpression were also revealed. Finally, a logistic regression model was built to evaluate the combined diagnostic capability of GNGT1 and NMU.

2.1. Downloading of TCGA Datasets and DEG Screening. The mRNA expression data of NSCLC patients were downloaded from the TCGA database (https://cancergenome.nih.gov/) [48] . The criteria used were as follows: primary site (lung), data category (Transcriptome Profiling), project ID (TCGA-LUAD and TCGA-LUSC), experimental strategy (RNA-Seq), and workflow type (HTSeq-counts). The other filters were kept as default. Practical Extraction and Reporting Language (Perl) was utilized to extract the sample information, generate the mRNA expression matrix, and annotate gene symbols. Finally, data from a cohort containing 1,145 samples were obtained from TCGA. Of these 1,145 samples, there were 108 normal tissue and 1,037 NSCLC samples, respectively. The EdgeR package from Bioconductor was used to screen the DEGs between normal tissue and NSCLC [49] [50] [51] . The adjusted P < 0:001, and fold change ðFCÞ > 4 were set as the cutoff criteria.

Analysis. Gene ontology (GO) analysis provides a standardized description of gene products in terms of molecular function (MF), biological process (BP), and cellular component (CC) [52] . The Kyoto Encyclopedia of Genes and Genomes (KEGG) is a database offering gene functional meanings and expressed proteins [53] . GO and KEGG enrichment analyses were conducted using the powerful online tool DAVID (DAVID, https:// david.ncifcrf.gov/) and visualized by the R package "ggplot2" [54] . In addition, P < 0:05 was considered to indicate statistical significance.

The Search Tool for the Retrieval of Interacting Genes (STRING, https://string-db.org/) database, a database that integrates all functional interactions between proteins, was used to build the PPI network [55] . An interaction score of ≥0.4 was considered statistically significant.

A Cytoscape plugin, Molecular Complex Detection (MCODE), was utilized to screen modules of PPI networks with a node score cutoff of 0.2, degree cutoff of 2, k-core of 2, and max depth of 100. A P value of <0.05 was considered statistically significant. Next, the DEGs were ranked by cytoHubba [56] , which contains 12 algorithms: Maximal Clique Centrality, Edge Percolated Component, Betweenness, Density of Maximum Neighborhood Component, Degree, Bottleneck, Eccentricity, Closeness, Radiability, Maximum Neighborhood Component, Stress, and Clustering Coefficient. The MCODE and cyto-Hubba results were combined to identify the hub genes.

2.5. Survival Analysis of Hub Genes. Whether the expression level of hub genes was associated with overall survival was investigated using the Kaplan-Meier plotter (http://www .kmplot.com/). An online database is capable of assessing the effect of 54,675 genes on survival using 10,461 cancer samples, including samples from 2,437 lung cancer, 1,065 gastric cancer, 1,816 ovarian cancer, and 5,143 breast cancer patients. P < 0:05 (Cox) was considered statistically significant.

2.6. ROC Curve. The ROC curve analysis was applied to evaluate the specificity and sensitivity of the hub genes. The area 2

Disease Markers under the curve (AUC) and P value were calculated. P < 0:05 was considered to denote statistical significance.

Genes. The expression level of hub genes in LUAD was validated by Oncomine (https://www .oncomine.org/resource/login.html) [57] . The threshold was set as the following: P < 1E − 4, fold change > 2, and gene ranking in the top 10%.

2.8. Human Protein Atlas. The Human Protein Atlas (https:// www.proteinatlas.org) is an online website that includes immunohistochemical data of nearly 20 types of tumors [58] . In our study, immunohistochemical images were used to directly compare the expression of biomarkers in normal and NSCLC tissues. The intensity of antibody staining indicated the protein expression of hub genes.

2.9. Genetic Alteration of Hub Genes. The cBio Cancer Genomics Portal (http://www.cbioportal.org/) is an open platform that provides visualization, analysis, and downloads of largescale cancer genomic datasets for various cancer types [59] . Complex cancer genomic profiles can be easily obtained using the portal's query interface, enabling researchers to explore and compare genetic alterations across samples. cBioPortal was used to explore genetic alterations, coexpression, and overall survival of two hub genes, GNGT1 and NMU.

2.10. Statistical Analysis. SPSS version 23.0 (SPSS Inc., Chicago, IL, USA) was used to perform logistic regression analysis. ROC curves were generated to evaluate the diagnostic accuracy of GNGT1 and NMU, and AUC was used to evaluate sensitivity and specificity.

The workflow is shown in Figure 1 (a). DEGs were identified using the criteria of P < 0:001 and FC > 4. A total of 1,411 DEGs were screened out between NSCLC and normal samples, including 1,362 upregulated genes and 49 downregulated genes (Figures 1(b) and 1(c)).

To further investigate the specific function of these genes, all DEGs were uploaded to the online tool DAVID. GO analysis revealed that in terms of BP, the DEGs were associated with nucleosome assembly, transcription from RNA polymerase II promoter, telomere organization, flavonoid glucuronidation, and DNA replication-dependent nucleosome assembly. When examined in terms of MF, DEGs were enriched in protein heterodimerization activity, retinoic acid-binding, hormone activity, glucuronosyltransferase activity, and extracellular ligand-gated ion channel activity. Regarding CC, the DEGs were mainly enriched in the extracellular region, cornified envelope, nucleosome, extracellular space, and intermediate filament. KEGG analysis found that the DEGs were predominantly involved in the Ras signaling pathway, nicotine addiction, steroid hormone biosynthesis, alcoholism, and systemic lupus erythematosus (Figure 2(a) ).

Gene Selection. The PPI network was constructed using the STRING database and visualized in Cytoscape. The PPI network consisted of 787 nodes and 2,104 edges, including 1,362 upregulated genes and 49 downregulated genes. The overlapping genes of different algorithms selected by cytoHubba were GNGT1, GNG4, NMU, GCG, TAC1, GAST, NPSR1, and GCGR (Figure 2(b) ). The top modules were then extracted from the PPI network (Figure 2(c) ). 

After studying the mRNA expression of hub genes in NSCLC, we tried to explore the protein expression of hub genes using the Human Protein Atlas. The results revealed that NMU protein was not expressed in normal lung tissues, whereas medium expression of NMU protein was observed in the NSCLC tissues. However, GNGT1 was not detected in either normal lung tissues or NSCLC tissues (Figure 4(c) ).

Alteration of Hub Genes. The two hub genes altered in 22 (4%) of the 584 patients, and the frequency of alteration of each hub gene, are shown in Figure 5 (a). GNGT1 and NMU were altered most often (2.7% and 1.7%, respectively), with mutation, amplification, and mRNA upregulation as the main types of alterations observed ( Figure 5(b) ). The expression of GNGTA was correlated with NMU (Spearman: 0.13, P = 2:415e − 3; Pearson = 0:13, P = 4:821e − 3) (Figure 5(c) ). Patients with CYP1A2 and GSTA3 alteration had worse overall survival than patients without CYP1A2 and GSTA3 alteration (P = 0:465) ( Figure 5(d)) .

Notably, according to the ROC curve analysis, the AUC of GNGT1 was 0.903 (P < 0:0001). For NMU, the AUC was 

Elucidating the molecular mechanisms of the initiation and development of NSCLC would benefit the early diagnosis and targeted therapy efforts [60] [61] [62] [63] . In this study, we identified 1,362 upregulated genes and 49 downregulated genes and selected GNGT1, GNG4, NMU, GCG, TAC1, GAST NPSR1, and GCGR as hub genes using Molecular Complex Detection (MCODE) and cytoHubba. These genes were primarily enriched in terms of the Ras signaling pathway, steroid hormone biosynthesis, nicotine addiction, alcoholism, steroid hormone biosynthesis, and systemic lupus erythematosus.

The Ras signaling pathway is closely related to the occurrence and progression of most human tumors [64] [65] [66] [67] . The activation of RAS-RAF-MEK-MAPK in gene transcription Disease Markers regulation can promote proliferation, migration, and angiogenesis of cancer cells [68] [69] [70] . RAS-PI3K interaction is an important signaling node and potential therapeutic target in EGFR-mutant lung cancer [71] [72] [73] . In addition, steroid hormones were not previously considered to be involved with lung function [74] [75] [76] . However, numerous studies have reported that steroid hormones are important in normal lung development and function [77] , as well as in the pathogenesis of pulmonary diseases, including lung cancer [78] [79] [80] [81] . Cigarette smoking is a well-known risk factor for the occurrence and progression of malignant diseases [82] [83] [84] [85] . Nicotine, the major constituent in cigarette smoke, plays key roles in cancer progression [86] [87] [88] [89] . Nicotine likely promotes lung cancer cell proliferation by upregulating HIF-1α and SOCC components [90] [91] [92] [93] . It was demonstrated that nicotine increased NSCLC cell proliferation through nicotinic acetylcholine receptor-mediated signals [94] [95] [96] [97] . Nicotine can also induce the expression of embryonic stem cell factor Sox2, which is indispensable for self-renewal and the maintenance of stem cell properties in NSCLC cells [98] [99] [100] .

Several studies have been conducted to investigate the association between alcohol and lung cancer. Some studies have reported that alcohol is linked to a number of human diseases, including cancers [101] [102] [103] . Interestingly, another report shows that alcohol has nothing to do with lung cancer [104] . Thus, conducting further experiments is necessary to confirm whether lung cancer is attributable to alcohol abuse. All in all, the findings of these studies are consistent with our results.

In the current study, the expressions of GNGT1 and NMU were low both in the Oncomine and TCGA databases, indicating that GNGT1 and NMU may play a role as oncogenes. The transducin γ-subunit gene (GNGT1) has been localized to human chromosome 7 [104] and is associated with various forms of cancer [105] [106] [107] [108] . GNGT1 exerts effects in different tissues regulating cell proliferation, migration, adhesion, and apoptosis [109] [110] [111] . One study showed that GNGT1 could serve as a marker of medulloblastoma [112] . GNGT1 can be utilized to differentiate gastrointestinal stromal tumor and leiomyosarcoma, two cancers that have very similar histopathology, but require very different treatments [113] [114] [115] . In the current study, GNGT1 was significantly upregulated and high mRNA expression of GNGT1 was associated with poor overall survival in NSCLC patients. Furthermore, KEGG analysis showed that GNGT1 was involved in the Ras signaling pathway. Therefore, it is reasonable to regard GNGT1 as a hub gene of NSCLC. Further studies are needed to better understand GNGT1's association with NSCLC.

Neuromedin U (NMU) has been reported to exhibit early alterations associated with cancer, including lung cancer, pancreatic cancer, breast cancer, renal cancer, and endometrioid endometrial carcinoma, through promoting migration, invasion, glycolysis, a mesenchymal phenotype, a stem cell phenotype of cancer cells, and resistance to the antitumor immune response [116] [117] [118] . It is overexpressed in pancreatic cancer and increases the cancer invasiveness through the hepatocyte growth factor c-Met pathway [119] [120] [121] . A role has also been implicated for NMU in human breast can-cer and endometrial cancer [122] [123] [124] . The protein encoded by NMU can amplify ILC2 to drive allergic lung inflammation [125] . NMU is regulated by RhoGDI2, a metastasis inhibitor, which can be used as a target for lung metastasis. The expression of NMU is negatively correlated with prognosis in most types of cancer [126] [127] [128] . In the present study, the higher mRNA and protein expression of NMU were negatively correlated with overall survival. Therefore, our results are in line with these previous studies, which indicated that NMU may be directly or indirectly important in NSCLC development.

Moreover, to explore the predictive ability of GNGT1 and NMU, logistic regression analysis was performed. The logistic regression analysis showed a probabilistic nonlinear regression, which has functions in discrimination and prediction. Notably, according to logistic regression analysis, the AUC of the ROC curve of GNGT1 was 0.903 (P < 0:0001), and the AUC of NMU was 0.932 (P < 0:0001). Combining the two biomarkers enabled a relatively high capacity for discrimination between NSCLC and normal patients, with an AUC of 0.969, indicating that the combined test of GNGT1 combined with NMU was superior to testing for either gene individually, with better clinical accuracy and higher diagnostic value. Therefore, it is of high scientific value to use a logistic regression model as a diagnostic model for NSCLC.

In conclusion, our results identified two hub genes, GNGT1 and NMU, as prognostic target genes, and highlighted their probable role in NSCLC. Nevertheless, a few limitations to this study should be acknowledged. Because all the data analyzed in the current study were retrieved from the online databases, further independent experiments are required to validate our findings and to explore the molecular mechanism of the hub genes in NSCLC development and progression.

All data generated or analyzed during this study are included in this article.

Impact Statement. GNGT1 and NMU identified in the current study may empower further discovery of the molecular mechanisms underlying NSCLC's initiation and progression.

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14

Lipopolysaccharide-anchored macrophages hijack tumor microtube networks for selective drug transport and augmentation of antitumor effects in orthotopic lung cancer

Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018

Transbronchoscopic patient biopsy-derived xenografts as a preclinical model to explore chemorefractory-associated pathways and biomarkers for small-cell lung cancer

Tumor-associated macrophages promote lung metastasis and induce epithelialmesenchymal transition in osteosarcoma by activating the COX-2/STAT3 axis

Large-scale pharmacogenomics based drug discovery for ITGB3 dependent chemoresistance in mesenchymal lung cancer

Stapled peptide targeting the CDK4/Cyclin D interface combined with Abemaciclib inhibits KRAS mutant lung cancer growth

Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo-and gene therapy

Met is involved in TIGARregulated metastasis of non-small-cell lung cancer

Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of nonsmall cell lung cancer (NSCLC) with EGFR mutations

Clinical characteristics and prognosis of COVID-19 patients with initial presentation of lung lesions confined to a single pulmonary lobe

PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer

Efficient delivery of microRNA and antimiRNA molecules using an argininocalix [4] arene macrocycle

Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer

Shining a light on metabolic vulnerabilities in non-small cell lung cancer

LunX-CAR T cells as targeted therapy for non-small cell lung cancer

Tartrate-resistant acid phosphatase 5/ACP5 interacts with p53 to control the expression of SMAD3 in lung adenocarcinoma

Personality (at intrapsychic and interpersonal level) associated with quality of life in patients with cancer (lung and colon)

The roles of exosomal miRNAs and lncRNAs in lung diseases

Peptide-targeted polyplexes for aerosol-mediated gene delivery to CD49f-overexpressing tumor lesions in lung

Spatiotemporal analysis of lung cancer histological types in Kentucky

Dysregulation of glutaminase and glutamine synthetase in cancer

Aberrant microRNAomics in pulmonary complications:implications in lung health and diseases

Association of opioid use in the week before death among patients with advanced lung cancer having sepsis

A drug-tunable gene therapy for broad-spectrum protection against retinal degeneration

Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanoma

Evaluation of novel formulations for transarterial chemoembolization: combining elements of Lipiodol emulsions with drug-eluting beads

lncRNA PVT1 promotes tumorigenesis of colorectal cancer by stabilizing miR-16-5p and interacting with the VEGFA/VEGFR1/AKT axis

Circular RNA circSATB2 promotes progression of non-small cell lung cancer cells

Concurrent driver gene mutations as negative predictive factors in epidermal growth factor receptor-positive non-small cell lung Cancer

Natural compound Tetrocarcin-A downregulates Junctional Adhesion Molecule-A inconjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumorcell growth

A novel asymmetrical anti-HER2/CD3 bispecific antibody exhibits potent cytotoxicity for HER2-positive tumor cells

Co-occurring alterations of ERBB2 exon 20 insertion in non-small cell lung cancer (NSCLC) and the potential indicator of response to afatinib

Histone deacetylase inhibitor sensitizes ERCC1-high non-small-cell lung cancer cells to cisplatin via regulating miR-149

HDAC6-specific inhibitor suppresses Th17 cell function via the HIF-1α pathway in acute lung allograft rejection in mice

Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis

A rapid liquid biopsy of lung cancer by separation and detection of exfoliated tumor cells from bronchoalveolar lavage fluid with a dual-layer "PER-FECT" filter system

N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1

LunX-CAR T Cells as a targeted therapy for non-small cell lung cancer

lncRNA UCA1 promotes gefitinib resistance as a ceRNA to target FOSL2 by sponging miR-143 in non-small cell lung cancer

Exome sequencing identifies somatic mutations in novel driver genes in non-small cell lung cancer

Direct targeting of HSP90 with daurisoline destabilizes β-catenin to suppress lung cancer tumorigenesis

The intensity of hospital care utilization by Dutch patients with lung or colorectal cancer in their final months of life

Identification of genes and analysis of prognostic values in nonsmoking females with non-small cell lung carcinoma by bioinformatics analyses

Long Noncoding RNA LINC01116 contributes to gefitinib resistance in non-small cell lung cancer through regulating IFI44

Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits

Comprehensive molecular profiling of lung adenocarcinoma

Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma

Comprehensive analysis of lncRNA-miRNA-mRNA network ascertains prognostic factors in patients with colon cancer

edgeR: a bioconductor package for differential expression analysis of digital gene expression data

Gene ontology: tool for the unification of biology

KEGG: Kyoto Encyclopedia of Genes and Genomes

PKgraph:an R package for graphically diagnosing population pharmacokinetic models

Update of the G2D tool for prioritization of gene candidates to inherited diseases

cytoHubba: identifying hub objects and sub-11

Disease Markers networks from complex interactome

ONCOMINE: a cancer microarray database and integrated data-mining platform

miR-124 intensified oxaliplatin-based chemotherapy by targeting CAPN2 in colorectal cancer

Targeting extracellular miR-21-TLR7 signaling provides long-lasting analgesia in osteoarthritis

A novel benzofuran derivative Moracin N induces autophagy and apoptosis through ROS generation in lung cancer

QT interval prolongation related to afatinib treatment in a patient with metastatic non-small-cell lung cancer

IL10 deficiency promotes alveolar enlargement and lymphoid dysmorphogenesis in the aged murine lung

IL-1β suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury

Small molecule KRAS agonist for mutant KRAS cancer therapy

Combinative treatment of βelemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation

circFMN2 sponges miR-1238 to promote the expression of LIM-homeobox gene 2 in prostate cancer cells

Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression

Mouse models of thyroid cancer: bridging pathogenesis and novel therapeutics

Radiation-induced DNMT3B promotes radioresistance in nasopharyngeal carcinoma through methylation of p53 and p21

STAT3: a key signaling molecule for converting cold to hot tumors

Polymorphic regionspecific antibody for evaluation of affinity-associated profile of chimeric antigen receptor

Dual-targeting of EGFR and Neuropilin-1 attenuates resistance to EGFR-targeted antibody therapy in KRAS-mutant non-small cell lung cancer

Lung cancer survival in never-smokers and exposure to residential radon: results of the LCRINS study

Analysis of lung adenocarcinoma subtypes based on immune signatures identifies clinical implications for cancer therapy

Radiation-induced small extracellular vesicles as "carriages" promote tumor antigen release and trigger antitumor immunity

RPL32 promotes lung cancer progression by facilitating p53 degradation

NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells

Potential applications for sigma receptor ligands in cancer diagnosis and therapy

HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis

LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 andphosphorylation of AKT in EGFR-mutant lung cancers

Esophageal, gastric and colorectal cancers: looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology

Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatinresistant lung cancer cells through JAK/STAT3/PD-L1 pathway

Exacerbation of symptomatic arthritis by cigarette smoke in experimental arthritis

Attenuation of the pro-inflammatory signature of lung cancer-derived mesenchymal stromal cells by statins

MicroRNA modification of Coxsackievirus B3 decreases its toxicity, while retaining oncolytic potency against lung cancer

Enhancer reprogramming within pre-existing topologically associated domains promotes TGF-β-induced EMT and cancer metastasis

Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-12 Disease Markers TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer

Ultrasmall gold nanoparticles in cancer diagnosis and therapy

Crosstalk between let-7a-5p and BCL-xL in the initiation of toxic autophagy in lung cancer

A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma

Nck-associated protein 1 associates with HSP90 to drive metastasis in human non-smallcell lung cancer

Downregulation of the circadian rhythm regulator HLF promotes multiple-organ distant metastases in non-small cell lung cancer through PPAR/NF-κb signaling

Exosomal leucine-rich-Alpha2-glycoprotein 1 derived from non-small-cell lung cancer cells promotes angiogenesis via TGF-β signal pathway

Neddylation: a novel modulator of the tumor microenvironment

Insulin-like growth factor-1 receptor induces immunosuppression in lung cancer by upregulating B7-H4 expression through the MEK/ERK signaling pathway

Extracellular vesicles from human umbilical cord blood plasma modulate interleukin-2 signaling of T cells to ameliorate experimental autoimmune encephalomyelitis

α5-nAChR contributes to epithelial-mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer

Targeting late-stage nonsmall cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade

MICAL2 is a novel nucleocytoplasmic shuttling protein promoting cancer invasion and growth of lung adenocarcinoma

LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway

Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway

Phytochemical analysis, antioxidant, antibacterial, cytotoxic, and enzyme inhibitory activities of Hedychium flavum rhizome

Low-dose interleukin-2 alleviates dextran sodium sulfate-induced colitis in mice by recovering intestinal integrity and inhibiting AKTdependent pathways

DHRS2 mediates cell growth inhibition induced by Trichothecin in nasopharyngeal carcinoma

Gene structure and chromosome localization to 7q21.3 of the human rod photoreceptor transducin gammasubunit gene (GNGT1)

Gene structure and chromosome localization of the GγcSubunit of human cone G-protein (GNGT2)

Expression of the G protein gammaT1 subunit during zebrafish development

Transducin duplicates in the zebrafish retina and pineal complex:differential specialisation after the teleost tetraploidisation

Genome-wide meta-analyses identifies novel taxaneinduced peripheral neuropathy-associated loci

Central and C-terminal domains of heterotrimeric G protein gamma subunits differentially influence the signaling necessary for primordial germ cell migration

Transcriptomic analyses of tributyltin-induced sexual dimorphisms in rare minnow (Gobiocypris rarus) brains

Predicting responses to platin chemotherapy agents with biochemically-inspired machine learning

Bioinformatic gene analysis for potential biomarkers and therapeutic targets of atrial fibrillation-related stroke

Comprehensive analysis of core genes and potential mechanisms in rectal cancer

Uveitis and multiple sclerosis: potential common causal mutations

Disease Markers

Inactivation of the von Hippel-Lindau tumour suppressor gene induces Neuromedin U expression in renal cancer cells

A novel hypothesis-unbiased method for Gene Ontology enrichment based on transcriptome data

Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells

Neuromedin U alters bioenergetics and expands the cancer stem cell phenotype in HER2-positive breast cancer

Neuromedin U precursor-related peptide (NURP) exerts neuromedin Ulike sympathetic nerve action in the rat

Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U

Abnormal DNA methylation may contribute to the progression of osteosarcoma

Neuromedin U signaling regulates retrieval of learned salt avoidance in a C. elegans gustatory circuit

Systems biology integration and screening of reliable prognostic markers to create synergies in the control of lung cancer patients

Commentary: neuronal regulation of type 2 innate lymphoid cells via neuromedin U

The short interference RNA (siRNA) targeting NMUR2 relieves nociception in a bone cancer pain model of rat through PKC-ERK and PI3K-AKT pathways

An optical brain-to-brain interface supports rapid information transmission for precise locomotion control

Purification and identification of native forms of goldfish neuromedin U from brain and gut

Control of locomotor speed, arousal, and hippocampal theta rhythms by the nucleus incertus

This study was supported partly by grants from the National Natural Science Foundation of China (81972214, 81772932